Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
cancer
4
×
life sciences
national blog main
national top stories
new york blog main
startups
4
×
biotech
boston top stories
clinical trials
new york top stories
san francisco blog main
san francisco top stories
biogen
boulder/denver blog main
boulder/denver top stories
deerfield management
detroit blog main
detroit top stories
europe blog main
europe top stories
fda
general atlantic
gilead sciences
indiana blog main
indiana top stories
ipo
melinta therapeutics
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
What
medicines
4
×
bio
covid
ipo
new
roundup
years
acquisitions
activity
adding
ago
aim
aiming
announced
approvals
balance
biogen
boost
build
cancer
ceo
change
clamped
collabs
community
daniel
deal
decibel
delays
developing
diagnostics
docs
drugs
economic
emerged
fast
fda
flatiron
focus
forms
Language
unset
Current search:
startups
×
cancer
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Decibel Therapeutics Strikes a Balance, Adding Regenerative Med Focus
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
